| Elissa Marie Schoffstall, | |
|
3237 E Maldonado Dr, Phoenix, AZ 85042-6115 | |
| (480) 336-0278 | |
| Not Available |
| Full Name | Elissa Marie Schoffstall |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 3237 E Maldonado Dr, Phoenix, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215540513 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Secondary |
| 225XP0200X | Occupational Therapist - Pediatrics | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elissa Marie Schoffstall, 3237 E Maldonado Dr, Phoenix, AZ 85042-6115 Ph: (480) 336-0278 | Elissa Marie Schoffstall, 3237 E Maldonado Dr, Phoenix, AZ 85042-6115 Ph: (480) 336-0278 |
News Archive
Ninth Annual World Conference of the Human Proteome Organization - Agilent Technologies Inc. (NYSE:A) today announced that its collaboration with the Institute for Systems Biology (ISB) and the Swiss Federal Institute of Technology (ETH Zurich) for the mapping of the complete human proteome by mass spectrometry is entering its second phase.
Copenhagen has been struggling with air pollution for many years now. Pollution from lorries, vans, busses and cars each year costs lives.
Probably nothing causes members of Congress more unease than having to talk about death. It's only been four years since healthcare reform became more about whether President Obama wanted to throw mama from a train via "death panels" than, well, how best to reform a broken healthcare system. Still, there are several representatives from both parties who want to discuss it (Daniel Rothberg, 7/22).
Researchers have developed a simple scoring system, based on a patient's age, health issues, and education, which accurately predicts the risk of dementia in people aged over 60 with type 2 diabetes.
Human Genome Sciences, Inc. today announced interim results through Week 12 following the end of treatment in a Phase 2b clinical trial conducted by Novartis to evaluate the safety and efficacy of ZALBIN™ (albinterferon alfa-2b), an investigational agent, administered monthly in combination with ribavirin in 391 treatment-naive patients with genotypes 2 and 3 chronic hepatitis C virus. The primary efficacy endpoint is sustained virologic response (SVR) at Week 48 (24 weeks following the end of treatment).
› Verified 4 days ago
Rebecca Ebbert, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7540 N 19th Ave, Phoenix, AZ 85021 Phone: 888-873-4221 Fax: 888-543-2289 | |
Kristina Nalder, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5314 N 7th St, Phoenix, AZ 85014 Phone: 602-277-5006 | |
Tabitha Macziewski, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4600 E Shea Blvd, Suite 101, Phoenix, AZ 85028 Phone: 602-368-8601 Fax: 602-368-8605 | |
Christina Hyland, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4641 N 12th St Ste 100, Phoenix, AZ 85014 Phone: 602-281-2896 | |
Kristel Ferrer, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5025 E Washington St Ste 108, Phoenix, AZ 85034 Phone: 602-313-8999 | |
Giovanna Martinez, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 4125 N 14th St, Phoenix, AZ 85014 Phone: 602-882-5544 | |
Courtney Boyce, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 13201 S Wakial Loop Apt 1094, Phoenix, AZ 85044 Phone: 602-882-2345 |